ClinicalTrials.gg
RecruitingNCT06904079Updated Aug 17, 2025

Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Analysis and AI Agents

An interventional study of Gamified Digital Rehabilitation and Routine Care in Severe Mental Disorder, Schizophrenia and Schizoaffective Disorder, sponsored by Shanghai Mental Health Center. Recruiting at 1 site in China. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-08-17.

Sponsored by Shanghai Mental Health Center · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as recruiting.
  • Registered 1 year after the study started (first participant enrolled Mar 2024, registered Mar 2025).
  • Started Mar 2024; still recruiting 2 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
82
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Mental health issues represent a major public health and social problem that significantly impacts economic and social development. Compared to other diseases, mental disorders can impair various aspects of a patient' s life, including psychological, social, occupational, and educational functions, affecting their quality of life and daily living abilities. Particularly, severe mental disorders tend to have a chronic course, often resulting in diminished social functions and social withdrawal, making it difficult for patients to integrate into society. Repeated, systematic, and comprehensive rehabilitation training for patients with severe mental disorders can effectively control or delay disease recurrence, improve social functions, enhance quality of life, and facilitate patients' reintegration into society.

In recent years, the scope of mental disorder rehabilitation has expanded to include enhancing patients' social functions and promoting their integration into society. Vocational rehabilitation and social skills training are widely used in the rehabilitation treatment of patients with severe mental disorders, and some physical intervention methods, such as neurofeedback training, have also proven to be significantly effective in the rehabilitation process. However, traditional rehabilitation techniques often lack specificity and fail to meet individualized needs of patients. Additionally, the rehabilitation process lacks long-term monitoring, making it challenging to continuously assess and adjust patients' rehabilitation outcomes. Furthermore, the assessment of rehabilitation effectiveness mainly relies on patients' subjective feelings and clinical observations, lacking high-quality evidence. Therefore, there is an urgent need to introduce new rehabilitation technologies and scientifically evaluate their effectiveness to address the shortcomings of traditional methods and provide more personalized, precise, and effective rehabilitation support.

With the rise of digital health technologies, the field of mental health rehabilitation has encountered new opportunities. Compared to traditional therapies, digital health is revolutionizing the healthcare industry, moving away from traditional approaches to healthcare management to real-time personalized monitoring and therapeutic care.Technologies such as remote monitoring, virtual reality, and computer-assisted cognitive correction therapy are increasingly applied in rehabilitation. However, these methods still need improvements in data management and integration capabilities. A large amount of data accumulates in systems, recording only the training process and real-time effects of patients, without further evaluating their rehabilitation status, leading to resource waste. Therefore, there is an urgent need to develop a digital rehabilitation model that better meets the genuine needs of patients with severe mental disorders.

This study aims to integrate multimodal technology, reinforcement learning, and agent-based modeling (ABM) into the research of mental health rehabilitation to more accurately assess and predict the rehabilitation status of mental disorder patients and to more effectively guide and support decision-making in mental rehabilitation treatment.

Read the detailed description

This study aims to integrate multimodal technology, reinforcement learning(RL), and agent-based modeling (ABM) into the research of mental health rehabilitation to more accurately assess and predict the rehabilitation status of mental disorder patients and to more effectively guide and support decision-making in mental rehabilitation treatment.

This research project is divided into three main phases: theoretical and experimental phase, multimodal analysis phase, and application and optimization phase.

Firstly, we will conduct in-depth research across 20 community mental health facilities in Shanghai. This will be combined with an analysis of existing literature and studies to understand the needs of potential users, providing theoretical support and design basis for subsequent gamification interventions. This phase of user feedback, literature review, and needs assessment will offer directional guidance for the entire research.

In the second phase, based on the user needs and literature analysis results from the previous phase, we will design and implement gamification interventions, followed by a randomized controlled trial. Simultaneously, we will collect and analyze game behavior data to systematically evaluate the actual effects of the gamification interventions. This phase, focusing on intervention design and effect evaluation, is the core part of the research, and user feedback will continuously guide us in optimizing the interventions.

In the third phase, using the Multimodal and Crossmodal AI framework(MMCRAI), we will analyze multimodal data including patients' game behavior, physiological indicators, and psychological health information to better understand the key factors and dynamic changes in the rehabilitation process. This will provide training signals for the subsequent modeling and optimization phase.

Finally, combining agent-based models and reinforcement learning algorithms, we will simulate and predict the effects of gamification interventions in actual community settings, thus translating theoretical and experimental results into practical guidelines. In this phase, we will validate the effectiveness of the agent-based model through real-world application scenarios and discuss potential limitations and assumptions.

Overall, these four phases are interrelated and logically coherent, progressively deepening our understanding of the mental health rehabilitation process and forming a complete research framework, thereby laying a solid foundation for practical applications. Throughout the study, we will uphold ethical principles and privacy policies, ensuring that all research activities comply with regulations.

02

Conditions studied

  • Severe Mental Disorder
  • Schizophrenia
  • Schizoaffective Disorder
  • Paranoid Psychosis
  • Bipolar Affective Disorder
  • Mental Disorders Due to Epilepsy
  • Mental Retardation Accompanied by Mental Disorders

Keywords

  • Severe Mental Disorder
  • Reinforcement Learning
  • Agent-based Modeling
  • Multimodal and Crossmodal AI framework
  • Digital rehabilitation
03

In context

Mental Disorders

1,746 studies on the registry are indexed under Mental Disorders; 350 are open to participants now.

This study's planned enrollment of 82 is below the median of 100 across 1,305 interventional studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

Shanghai Mental Health Center is the lead sponsor of 277 studies on the registry; 95 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Registered in the Shanghai Mental Health Information Management System,

    • Diagnosed patients with one of the six severe mental disorders: schizophrenia, schizoaffective disorder, paranoid psychosis, bipolar (affective) disorder, mental disorder due to epilepsy, and mental retardation accompanied by mental disorder,

      • Aged between 18 and 65 years old, ④ Normal vision or hearing, or within the normal range after correction, ⑤ Patients or their families have provided for this study and signed the informed consent form.

Exclusion criteria

Exclusion criteria:

Patients with severe physical illnesses or organic brain diseases.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
82 participants (estimated)

Study arms

  • Experimental
    Intervention Group (Gamified Digital Rehabilitation)

    Participants in this arm will receive routine pharmacological treatment and standard community rehabilitation services, combined with a structured, story-based gamified digital rehabilitation intervention. The interventions are digital functional games five times a week (30 minutes each) for 3 months.

    Other: Gamified Digital Rehabilitation · Behavioral: Routine Care

  • Active comparator
    Control Group (Routine Care)

    Participants in this arm will receive routine pharmacological treatment and standard community rehabilitation services during the same period.

    Behavioral: Routine Care

Interventions

  • OtherGamified Digital Rehabilitation

    The gamification intervention measures are as follows: Currently, the initial version of the community mental health rehabilitation interactive game mainly focuses on six dimensions of medication management, including the importance of taking medication, identifying and dealing with adverse reactions to antipsychotic drugs, learning self-management of medication, assessing the effectiveness of medication treatment, long-term management of medication treatment, and discussing issues related to medication effects with medical staff. Next, we will continue to design a series of games themed on symptom management and psychological rehabilitation, and implement game-based digital rehabilitation interventions for patients in the intervention group based on these games.

  • BehavioralRoutine Care

    Receive regular psychiatric medication treatment and regular community rehabilitation services, including regular follow-ups, rehabilitation guidance, and community education,etc.

06

What researchers measure

Primary outcomes

  1. BPRS reduction rate

    The Brief Psychiatric Rating Scale (BPRS) was used to measure the presence and severity of psychiatric symptoms entailing positive symptoms, general psychopathology, and affective symptoms (e.g., thought disturbance, emotional withdrawal, hostility, and suspiciousness) for patients with mental illness, particularly schizophrenia. Each of the 18 items are designed to represent a discrete symptom area. Items are rated on a 7-point Likert scale, from 1 = 'not present' to 7 = 'extremely severe', with scores ranging from 18 to 126 (achieved through summing the item scores). Higher scores indicated more severity of psychiatric symptoms. Reduction rate was calculated using the following formula: reduction rate= (Score before treatment-Score after treatment)/(Score before treatment-18) × 100%. A reduction rate of BPRS score \> 25% was considered as a clinically meaningful improvement.

    Time frame: Baseline (pre-intervention), immediately post-intervention (3 months), 1-month follow-up (4 months), 3-month follow-up (6 months) and 6-month follow-up (9 months).

Secondary outcomes

  1. MMAS-8

    The 8-item Morisky medicationadherence scale is the most widely used medication compliance assessment scale, which has been applied to patients with multiple chronic diseases and has been translated into different languages.

    Time frame: Baseline (pre-intervention), immediately post-intervention (3 months), 1-month follow-up (4 months), 3-month follow-up (6 months) and 6-month follow-up (9 months).

  2. GAD-7

    The Generalized Anxiety Disorder Screener (GAD-7) is a brief, 7-item self-report measure for anxiety symptoms in adolescents and adults. Although developed primarily as a screening tool for GAD, it can also be used as a diagnostic tool to monitor changes in symptoms over time, and as a screener for social anxiety, panic disorder, and post-traumatic stress disorder. Each item is rated on a likert-type scale from zero ('not at all') to three ('nearly every day'), with total scores ranging from 0 to 21.

    Time frame: Baseline (pre-intervention), immediately post-intervention (3 months), 1-month follow-up (4 months), 3-month follow-up (6 months) and 6-month follow-up (9 months).

  3. PHQ-9

    The Patient Health Questionnaire-9 (PHQ-9) is a multipurpose instrument for screening , diagnosing, monitoring and measuring the severity of depression. The tool rates the frequency of the symptoms which factors into the scoring severity index. The PHQ -9 is brief and useful in clinical practice. The PHQ -9 can be administered repeatedly , which can reflect improvement or worsening of depression in response to treatment .Each item is rated on a likert-type scale from zero ('not at all') to three ('nearly every day').

    Time frame: Baseline (pre-intervention), immediately post-intervention (3 months), 1-month follow-up (4 months), 3-month follow-up (6 months) and 6-month follow-up (9 months).

  4. WHOQOL-BREF

    The WHO Quality of Life Scale-Brief (WHOQOL-BREF) was developed by the Word Health Organisation as a quality of life assessment that would be applicable cross-culturally. It is a 26 item self report measure, especially useful for measuring outcomes with adults with a psychosocial disability. The WHOQOL-BREF measures four factors: physical health, psychological Health, social relationships, and environment. The total score is presented between 26 and 156, where higher scores represent higher levels of quality of life.

    Time frame: Baseline (pre-intervention), immediately post-intervention (3 months), 1-month follow-up (4 months), 3-month follow-up (6 months) and 6-month follow-up (9 months).

  5. SDSS

    The 10-item social disability screening schedule (SDSS) was used for measuring social function. It is a shortened version of psychiatric disability assessment schedule (DAS). SDSS was used to evaluate social disability, with 10 items in total, 0\~2 points for each item.

    Time frame: Baseline (pre-intervention), immediately post-intervention (3 months), 1-month follow-up (4 months), 3-month follow-up (6 months) and 6-month follow-up (9 months).

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2024 (actual). Primary completion is estimated for Jun 2026, 27 months after the start.

Of 668 non-industry interventional studies with no phase under Mental Disorders, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 45. This study's planned 27 months is close to that.

Counting every sponsor, half of 682 studies reached it within 29 months; a quarter within 13 and three quarters within 45.

Mental Disorders covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 25, 2025
First posted
Apr 1, 2025
StartActual
Mar 12, 2024
Primary completionEst.
Jun 30, 2026
CompletionEst.
Jun 30, 2026
Last update
Aug 17, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06904079
Responsible party
Sponsor
First posted
Apr 1, 2025
Start date
Mar 12, 2024
Primary completion
Jun 30, 2026 (estimated)
Completion
Jun 30, 2026 (estimated)
Last update
Aug 17, 2025

Study contacts

Weibo Zhang
Contact
zhangweibo600@163.com
86-13764694223
Jun Cai
principal investigator · Shanghai Mental Health Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion